Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Zepeda-PenaACGurrola-DiazCMDominguez-RosalesJAGarcia-LopezPMPizano-AndradeJCHernandez-NazaraZHet al
After using the GLS1 inhibitors BPTES, CB-893 or silencing by siRAN to form siGLS1, the expression activity of GLS1 in tumor cells was weakened, which could significantly inhibit tumor cell migration(Chen et al
Researchers are conducting clinical trials to determine the effectiveness of these adjunct therapies
Key Research Use Cases and Mechanisms In laboratory models, the combination of a GHRH analogue and a ghrelin agonist typically demonstrates what is known as a synergistic effect
US$ 20.14
US$ 20.07
US$ 29.13
US$ 25.56
US$ 28.98
US$ 24.02
US$ 21.56
.jpg&w=2048&q=75)
